AbCellera Biologics Inc. ABCL Property, Plant and Equipment and Operating Lease Right of Use Assets, before Accumulated Depreciation and Amortization
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept abcl:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetsBeforeAccumulatedDepreciationAndAmortization.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s property, plant and equipment and operating lease right of use assets, before accumulated depreciation and amortization.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s property, plant and equipment and operating lease right of use assets, before accumulated depreciation and amortization?
- AbCellera Biologics Inc. (ABCL) reported property, plant and equipment and operating lease right of use assets, before accumulated depreciation and amortization of $486.34M in Q1 2026.
- How has AbCellera Biologics Inc.'s property, plant and equipment and operating lease right of use assets, before accumulated depreciation and amortization changed year-over-year?
- AbCellera Biologics Inc.'s property, plant and equipment and operating lease right of use assets, before accumulated depreciation and amortization increased by 24.4% year-over-year, from $391.08M to $486.34M.
- What is the long-term trend for AbCellera Biologics Inc.'s property, plant and equipment and operating lease right of use assets, before accumulated depreciation and amortization?
- Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s property, plant and equipment and operating lease right of use assets, before accumulated depreciation and amortization has grown at a 23.5% compound annual growth rate (CAGR), from $318.3M to $485.62M.